Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dwarfism, Pituitary

• A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial
• Growth Hormone Deficiency in Mild Traumatic Brain Injury
• GHRT in Veterans With Gulf War Illness and AGHD
• Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial LUM-201-01 Trial (OraGrowtH213 Trial)
• A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
• A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.
• AGH Replacement Therapy With mTBI
• PK and PD Study of LUM-201 in Children With Growth Hormone Deficiency
• A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is
• A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency
• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
• Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)
• Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
• Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency
• A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects
• Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
• Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
• Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
• A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
• Treatment of GHD Associated With CHF
• A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
• Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency
• A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
• Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
• Body Composition and Adipose Tissue in HIV
• Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function
• A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
• A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
• Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
• Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
• A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9
• Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
• A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
• Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
• Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
• Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
• Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
• Versartis International Trial in Adults With Long-Acting Growth Hormone
• Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
• Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers
• Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
• Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
• Study of TV-1106 in Growth Hormone-Deficient Adults
• A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
• A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency
• Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
• Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
• A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
• Versartis Long-Term Safety Study of Somavaratan
• Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
• A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency
• Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
• A Phase 3, Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product (Mod-4023) In Adult Subjects With Growth Hormone Deficiency
• GH and Cardiovascular Risk Factors
• Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
• Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency
• An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
• Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
• Phase 1 Safety Study of ALRN-5281 in Healthy Subjects
• Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
• Versartis Trial in Children to Assess Long-Acting Growth Hormone
• A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency
• Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
• Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
• Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
• Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
• Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
• French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin
• Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure
• Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
• Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
• Safety and Efficacy of Long-term Somatropin Treatment in Adults
• Safety and Efficacy of Long-term Somatropin Treatment in Children
• First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects
• Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
• Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers
• VRS-317 in Adult Subjects With Growth Hormone Deficiency
• Adipocyte Function and Somtropin Deficiency
• Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
• Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
• Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
• A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency
• A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
• Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
• Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
• MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)
• Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®
• A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
• Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency
• Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)
• Observational Study of Somatropin Treatment in Children
• A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults
• Peripheral Metabolic Effects of Somatostatin
• An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
• Observational Prospective Study on Patients Treated With Norditropin®
• Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
• A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone
• An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®
• A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin
• Growth Hormone and Glucose Metabolism
• A Study of Zomacton in Children With Growth Hormone Deficiency
• Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
• Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).
• Adult Growth Hormone Deficiency and Cardiovascular Risk
• Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
• Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
• Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
• Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
• Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency
• An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
• Drug Use Investigation of Somatropin for GHD-ADULTS.
• Sustained Release Formulation of Somatropin (rDNA Origin)for Injection
• Treatment of Adults With Growth Hormone Deficiency
• Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
• Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
• Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
• Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury
• Growth Hormone Deficiency in Adults (GHDA)
• Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
• Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)
• Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
• The Effects of Growth Hormone (GH) on Lipid Depots
• Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
• Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
• Practicability and Acceptability of Stylomax® in Children
• Effect of Pegvisomant on GH/IGF-I Relationship in GHD
• Effect of 5 Years of GH Replacement on Atherosclerosis
• The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
• rhGH Therapy on Hepatic Drug Metabolism
• A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
• Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.
• Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.
• Growth Hormone's Effect on the Cardiovascular System
• Growth Hormone and Endothelial Function in Children
• 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
• A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency
• A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency
• Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety
• Treatment of Adults With Growth Hormone Deficiency
• Treatment of Children With Insufficient Secretion of Growth Hormone
• Effect of Growth Hormone in Children With Growth Hormone Deficiency
• Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®
• A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
• Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency
• Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
• Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
• Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
• Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
• Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency
• Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
• Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
• Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
• Consequence of Lifetime Isolated Growth Hormone Deficiency
• Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
• Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
• Growth Hormone and Chromosome 18q- and Abnormal Growth
• Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
• Role of Nutrition and Hormones in Boys With Disordered Growth
• Testosterone and Growth Hormone for Bone Loss in Men
• Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency